Baggio D, Wellard C, Chung E, Talaulikar D, et al. Australian experience with ibrutinib in patients with relapsed/refractory mantle cell lymphoma: a study from the Lymphoma and Related Diseases Registry. Leuk Lymphoma 2023;64:621-627.
PMID: 38376128